GeneQuine Biotherapeutics to Present at BioTrinity Conference (May 11-13, 2015, London)

GeneQuine Biotherapeutics, developing gene therapy for joint diseases, will present at BioTrinity 2015, Europe’s leading Biopartnering and Investment Conference, on May 13, 2015 in London.

GeneQuine’s CEO Dr. Kilian Guse will showcase the company’s technology and product candidates as well as the recent results from a proof-of-concept study demonstrating symptomatic and disease-modifying treatment for osteoarthritis.